Clone of Partners in Shingles Prevention: Turning Patient Insights into Collaborative Immunization Strategies - Specialty Care

December 15, 2025 to December 14, 2026

A PI-NCPD, PI-CME and Portfolio project in primary care at Boston Medical Center to improve shingles vaccination for patients 50 and older or those taking immunosupressing agents provided by Boston University Chobanian and Avedisian School of Medicine, CCE.

Claiming Credit for This Activity

Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will then be prompted to claim your credit on the following page.

Use of Learner Data (MD Only): by completing the evaluation and attesting to meeting the meaningful participation requirements, you agree to allow us to share your completion data with the ACCME and the ABIM

Target Audience

Physicians, PAs, Nurses and others involved in the care of patients 50 and older or those taking immunosupressing agents.

Learning Objectives

Upon completion of this activity, learners should be able to: 

  1. Apply ACIP recommendations and EHR data insights to accurately identify adults eligible for shingles vaccination, including those at highest risk from immunosuppressive conditions or medications
  2. Implement EHR-based identification and guideline-supported strategies to raise shingles vaccination rates in eligible adults
  3. Apply patient-centered communication approaches that incorporate patient data insights and leverage care team coordination to increase shingles vaccination rates and series completion

This program is supported by an independent educational grant from Sanofi and Regeneron.

Course summary
Available credit: 
  • 30.00 ACPE Pharmacy
  • 30.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 30.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 30.00 MA Risk Management
  • 30.00 Participation
Course opens: 
12/15/2025
Course expires: 
02/28/2026
Event starts: 
12/15/2025 - 12:00am EST
Event ends: 
12/14/2026 - 11:59pm EST
Rating: 
0

Disclosure Policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Core QI Team and Planning Committee Disclosures

  • Andrea Mosquera, PharmD, Course Director; TBD, MD, Course Director; Bobby Siharath, PharmD, Core QI team; Kristopher Getzik, PharmD, Core QI Team; Natalie Sanfratello, MPH, Core QI Team; Alison Li, MPH, Core QI Team have no relevant relationships to disclose. 

 

ABMS Portfolio Program Sponsor Activity Logo

ABMS Portfolio Program
The QI Hub is approved as an American Board of Medical Specialties (ABMS) Portfolio Program Sponsor. This project has been approved for Maintenance of Certification (MOC) Part IV credit from the following boards: 

American Board of Internal Medicine: 30 Practice Assessment points

 

 

 

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this PI-CME Activity for a maximum of 30.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is approved for 30 CPE credit(s) under the ACPE universal activity number XXXXXX. The activity is available for credit claiming through February 28, 2027.

 

Available Credit

  • 30.00 ACPE Pharmacy
  • 30.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 30.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 30.00 MA Risk Management
  • 30.00 Participation
Please login or register to take this course.

Please click on "Take Course" above to begin the credit claiming process. 

Disclaimer

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.